The central hypothalamic melanocortin-4 receptor (MC4R) is a uniquely validated therapeutic target for the treatment of obesity based on both pharmacologic and human genetic evidence [1,2,3,4]. This evidence concerns the gene MC4R and obesity due to melanocortin 4 receptor deficiency.